Corporate governance

As an organisation, we seek to achieve and maintain best practice in corporate governance and the directors acknowledge the importance of the principles of the Quoted Companies Alliance Corporate Governance Code for Small and Mid-Sized Quoted Companies 2013 (QCA Code).

Although the QCA Code is not compulsory for companies listed on the Alternative Investment Market (AIM), the directors apply the principles of the QCA Code to the extent they consider appropriate for a company the size and nature of Vernalis in accordance with the QCA Code.

For a copy of the QCA Code, visit the Quoted Companies Alliance website at and click on Guides.

Below we have provided pdf copies of the terms of reference for each of our Board Committees together with our Code of Conduct and Ethics policy.



Audit Commitee

Remuneration Committee

Nomination & Corporate Governance Committee

Code of Conduct and Ethics

Executive Directors         Independent
Ian Garland selected     selected No
David Mackney selected       No 
Non-executive Directors


Peter Fellner selected (Chair)     selected (Chair) No
Carol Ferguson selected (SID) selected (Chair) selected (Chair) selected Yes 
Nigel Sheail selected  selected  selected Yes 
Lisa Schoenberg selected selected selected selected Yes 

Note: To view PDF files, you will need the Adobe Acrobat Reader. This can be downloaded free of charge from the Adobe website.

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and or FDA at 1-800-FDA-1088 or